Liminatus Pharma
(NASDAQ) LIMN
Liminatus Pharma Financials at a Glance
Market Cap
$8.34M
Revenue (TTM)
$0.00
Net Income (TTM)
$2.58M
EPS (TTM)
$-0.19
P/E Ratio
-1.14
Dividend
$0.00
Beta (Volatility)
1.16 (Average)
Dividend
$0.00
Beta (Volatility)
1.16 (Average)
Price
$0.20
Volume
1,632,454.525
Open
$0.21
Price
$0.20
Volume
1,632,454.525
Open
$0.21
Previous Close
$0.21
Daily Range
$0.19 - $0.21
52-Week Range
$0.19 - $33.66
Dividend
$0.00
Beta (Volatility)
1.16 (Average)
Price
$0.20
Volume
1,632,454.525
Open
$0.21
Previous Close
$0.21
Daily Range
$0.19 - $0.21
52-Week Range
$0.19 - $33.66
LIMN News
LIMN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Liminatus Pharma
Industry
Biotechnology
Sector
Health CareEmployees
3
CEO
Chris Kim
Website
liminatuspharma.comHeadquarters
La Palma, CA 90623, US
LIMN Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
2%
Return on Assets
-2%
Earnings Yield
-87.72%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$8.34M
Shares Outstanding
39.33M
Volume
1.63M
Short Interest
0.00%
Avg. Volume
8.79M
Financials (TTM)
Gross Profit
$0.00
Operating Income
$2.91M
EBITDA
$2.75M
Operating Cash Flow
$3.11M
Capital Expenditure
$0.00
Free Cash Flow
$3.11M
Cash & ST Invst.
$804.54K
Total Debt
$5.12M
Liminatus Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$8.34M
N/A
Market Cap/Employee
$2.78M
N/A
Employees
3
N/A
Net Income
$1.82M
-183.6%
EBITDA
$1.80M
-182.8%
Quarterly Fundamentals
Net Cash
$718.00K
+83.0%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$1.44M
-68.5%
Return on Assets
-1.92%
N/A
Return on Invested Capital
1.54%
N/A
Free Cash Flow
$613.72K
+15.9%
Operating Cash Flow
$600.61K
+17.7%